| http://www.w3.org/ns/prov#value | - BIO recognizes that payers, including CMS, have expressed concerns that some diagnostic tests in the market are superfluous, and may be ordered by a provider despite the fact that the result will not meaningfully alter how the provider will treat the patient.
|
